A novel sulindac derivative protects against oxidative damage by a cyclooxygenase-independent mechanism.

COX-1 COX-2 Oxidative stress aging cardiac ischemia ischemia / reperfusion injury oxidative injury oxygen radicals

Journal

The Journal of pharmacology and experimental therapeutics
ISSN: 1521-0103
Titre abrégé: J Pharmacol Exp Ther
Pays: United States
ID NLM: 0376362

Informations de publication

Date de publication:
09 Jun 2022
Historique:
accepted: 03 05 2022
received: 04 01 2022
revised: 30 04 2022
entrez: 9 6 2022
pubmed: 10 6 2022
medline: 10 6 2022
Statut: aheadofprint

Résumé

Oxidative damage is believed to play a major role in the etiology of many age-related diseases and the normal aging process. We previously reported that sulindac, a cyclooxygenase (COX) inhibitor and FDA approved anti-inflammatory drug, has chemoprotective activity in cells and intact organs by initiating a pharmacological preconditioning response, similar to ischemic preconditioning (IPC). The mechanism is independent of its COX inhibitory activity as suggested by studies on the protection of the heart against oxidative damage from ischemia/reperfusion and retinal pigmented endothelial (RPE) cells against chemical oxidative and UV damage

Identifiants

pubmed: 35680377
pii: jpet.122.001086
doi: 10.1124/jpet.122.001086
pmc: PMC9341458
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : P30 AG050911
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA131378
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA155638
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA197147
Pays : United States

Informations de copyright

Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics.

Références

Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19611-6
pubmed: 19884509
PLoS One. 2012;7(7):e39949
pubmed: 22866174
Circ Res. 2000 Nov 24;87(11):972-83
pubmed: 11090541
Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1455-60
pubmed: 15020304
Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H387-91
pubmed: 19429825
J Signal Transduct. 2012;2012:646354
pubmed: 21977319
Oxid Med Cell Longev. 2017;2017:9208489
pubmed: 28194256
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16754-9
pubmed: 25385631
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2155-8
pubmed: 7017726
Int J Mol Sci. 2016 Mar 08;17(3):351
pubmed: 27005615
PLoS One. 2009 Jun 05;4(6):e5804
pubmed: 19503837
Clin Interv Aging. 2018 Apr 26;13:757-772
pubmed: 29731617
Oncogene. 2015 Mar 19;34(12):1499-509
pubmed: 24704829
N Engl J Med. 1993 May 6;328(18):1313-6
pubmed: 8385741
Bioinformatics. 2004 Feb 12;20(3):389-98
pubmed: 14960466
Circ Res. 2000 Feb 18;86(3):264-9
pubmed: 10679476
Drug Metab Dispos. 2011 Jun;39(6):1014-21
pubmed: 21383205
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2095-9
pubmed: 8700890
Curr Heart Fail Rep. 2012 Sep;9(3):192-9
pubmed: 22798047
Genome Res. 2012 Sep;22(9):1813-31
pubmed: 22955991
Exp Neurobiol. 2015 Dec;24(4):325-40
pubmed: 26713080
Mol Cell Biochem. 2021 Mar;476(3):1631-1642
pubmed: 33417163
Development. 2001 Jun;128(11):1933-42
pubmed: 11493517
Biochem Biophys Res Commun. 2006 Oct 13;349(1):432-8
pubmed: 16945341
J Cell Biochem. 2019 Aug;120(8):14044-14054
pubmed: 30963607
J Pharmacol Exp Ther. 2009 Nov;331(2):574-90
pubmed: 19661377
Cancer Prev Res (Phila). 2011 Aug;4(8):1275-84
pubmed: 21505183
Int J Chron Obstruct Pulmon Dis. 2008;3(4):543-61
pubmed: 19281073
Oncotarget. 2016 Feb 2;7(5):5353-65
pubmed: 26713600
Cancer Res. 2000 Jul 1;60(13):3338-42
pubmed: 10910034
Clin Cancer Res. 2014 Mar 1;20(5):1104-13
pubmed: 24311630
J Cell Physiol. 2019 Feb;234(2):1190-1207
pubmed: 30132875
J Biomed Res. 2017 Jan 19;31(3):189-196
pubmed: 28808213
J Pharmacol Toxicol Methods. 2007 Mar-Apr;55(2):113-26
pubmed: 16844390
Cancer Prev Res (Phila). 2012 Jun;5(6):822-33
pubmed: 22556201
Brain Res. 2012 Oct 30;1482:71-80
pubmed: 22981403
Biochem Biophys Res Commun. 2003 Dec 26;312(4):1005-10
pubmed: 14651971
Pharmacol Ther. 2015 Mar;147:12-21
pubmed: 25444755
Cancer Res. 1997 Jul 15;57(14):2909-15
pubmed: 9230200

Auteurs

Shailaja Kesaraju Allani (SK)

Center for Molecular Biology and Biotechnology, Florida Atlantic University, United States hweissba@fau.edu.

Ramanjaneyulu Rayala (R)

Florida Atlantic University, United States.

Oscar Rivera (O)

Florida Atlantic University, United States.

Howard M Prentice (HM)

Florida Atlantic University, United States.

Xi Chen (X)

Auburn University, United States.

Veronica Ramírez-Alcántara (V)

University of South Alabama, United States.

Joshua Canzoneri (J)

University of South Alabama,, United States.

Janet Menzie-Suderam (J)

Florida Atlantic University, United States.

Xupei Huang (X)

Florida Atlantic University, United States.

Constantin Georgescu (C)

Oklahoma Medical Research Foundation, United States.

Jonathan D Wren (JD)

Oklahoma Medical Research Foundation, United States.

Gary A Piazza (GA)

Auburn University, United States.

Herbert Weissbach (H)

Florida Atlantic University, United States hweissba@fau.edu.

Classifications MeSH